Biotech Firm Wins Over Wall Street With Hopes for New Heart Drug

(Bloomberg) -- Medicines Co. is nearing the finish line in its journey to introduce a new type of cholesterol medicine that analysts expect to top $4 billion a year in sales.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.